- Home
- DSC vs PRLD Comparison
DSC vs PRLD Comparison
Compare DSC & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DSC | PRLD |
|---|---|---|
| Founded | 2013 | 2016 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 293.4M | 260.2M |
| IPO Year | 2023 | 2020 |
Fundamental Metrics
Financial Performance| Metric | DSC | PRLD |
|---|---|---|
| Price | $2.72 | $3.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $9.20 |
| AVG Volume (30 Days) | 20.4K | ★ 336.1K |
| Earning Date | 12-18-2026 | 11-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 23.21 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,140,000.00 |
| Revenue This Year | $15.21 | $258.83 |
| Revenue Next Year | $56.22 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 73.43 |
| 52 Week Low | $2.96 | $1.17 |
| 52 Week High | $9.60 | $6.83 |
Technical Indicators
Market Signals| Indicator | DSC | PRLD |
|---|---|---|
| Relative Strength Index (RSI) | 26.39 | 45.05 |
| Support Level | N/A | $3.38 |
| Resistance Level | $3.77 | $4.12 |
| Average True Range (ATR) | 0.36 | 0.33 |
| MACD | 0.00 | 0.04 |
| Stochastic Oscillator | 8.43 | 35.71 |
Price Performance
Historical ComparisonAbout DSC DSC Holdings Ltd. American Depositary Shares
DSC Holdings Ltd is an AI application infrastructure for China's used car industry. According to CIC, the Company has held over 90% market share in operating systems for China's used car dealers, giving it nationwide dealer connections and massive, granular, proprietary, real-time industry data. Building on this digital foundation, the group further supports used car dealers with essential transaction services across their workflows. Its Services engage and benefit thousands of dealer collaborators, such as inspectors, transporters, and other internet platforms, creating an ecosystem with used car dealers at its center.
About PRLD Prelude Therapeutics Incorporated
Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.